Nurs 5334 Exam 3 With Verified Solutions
Drugs Vfor VGestational VDiabetes V- V Vcorrect Vanswer- V VMetformin Vand VInsulin
A1C VValue Vfor VDiabetes VMellitus V- V Vcorrect Vanswer- V V6.5% Vor Vgreater Vis Vdiabetes, V5.7-6.4%
Vpre-diabetes
Fasting Vand VRandom VValues Vfor VDM V- V Vcorrect Vanswer- V VFasting Vplasma Vglucose—126 Vor
Vgreater Vis Vdiabetes. VRandom Vplasma Vglucose—anything Vgreater Vthan V200 Vis Vdiabetes
Complications Vof VInsulin VTherapy V- V Vcorrect Vanswer- V VHypoglycemia, VLipohypertrophy, VAllergic
Vreactions, VDesensitization Vprocedure, VHypokalemia
,Insulin VDrug VInteractions V- V Vcorrect Vanswer- V VHypoglycemic Vagents Vintensify Vhypoglycemia, VUse
Vwith Vcaution Vwith Vhyperglycemic Vagents
Beta VBlockers' VEffect Von VInsulin V- V Vcorrect Vanswer- V VDelay Vawareness Vof Vhypoglycemia, VImpair
Vglycogenolysis, VPrevent Vcounter-regulatory Vresponse
Other VTherapeutic VUses V- V Vcorrect Vanswer- V VHyperkalemia, VDiagnosis Vof VGH Vdeficiency,
VDiabetic Vketoacidosis
Coordinating VInsulin VDosage V- V Vcorrect Vanswer- V VCarbohydrate Vintake
Blood VPressure VGoal Vin VDiabetes V- V Vcorrect Vanswer- V VControlled Vwithin Vnormal V120/80
Medication Vfor VDiabetic VNephropathy VRisk V- V Vcorrect Vanswer- V VACE Vinhibitor Vor VARB
Role Vof VExercise Vin VDM VTreatment V- V Vcorrect Vanswer- V VExercise Vincreases Vcellular
Vresponsiveness Vto Vinsulin Vand Vglucose Vtolerance. V150 Vminutes Vper Vweek Vof Vmoderate Vintensity
Vexercise Vis Vrecommended.
4-Step VApproach VSteps V- V Vcorrect Vanswer- V VStep V1: VDiagnosis Vand Vlifestyle Vchanges Vplus
Vmetformin. VStep V2: VLifestyle Vchanges, Vmetformin, Vand Va Vsecond Vdrug. VStep V3: VThree Vdrug
Vcombination. VStep V4: VComplex Vinsulin Vregimen Vif Vneeded.
Insulin VTherapy VBlood VGlucose VGoals V- V Vcorrect Vanswer- V VBefore Vmeals: V70-130. VBedtime: V100-
140.
A1C VGoal Vand VExceptions V- V Vcorrect Vanswer- V VA1C Vgoal Vis V7% Vor Vbelow. VExceptions: VSevere
Vhypoglycemia Vrisk, Vlimited Vlife Vexpectancy, Vadvanced Vcomplications.
, Types Vof VInsulins V- V Vcorrect Vanswer- V VShort Vacting: VRapid Vacting Vinsulins. VIntermediate: VNPH
Vinsulin, Vinsulin Vdetemir. VLong Vacting: VInsulin Vglargine.
Use Vof VShort VDuration VInsulins V- V Vcorrect Vanswer- V VAdministered Vwith Vmeals Vto Vcontrol Vpost-
prandial Vblood Vglucose Vrise.
Need Vfor VIntermediate VInsulins V- V Vcorrect Vanswer- V VAdministered V2-3 Vtimes Vdaily Vfor Vglycemic
Vcontrol Vbetween Vmeals Vand Vat Vnight.
Duration Vof VInsulins V- V Vcorrect Vanswer- V VGlargine: VUp Vto V24 Vhours. VLevemir: V12-24 Vhours.
VDegludec: VUp Vto V42 Vhours.
Routes Vof VInsulin VAdministration V- V Vcorrect Vanswer- V VSubcutaneous Vinjection Vand VIV Vinfusion.
VInhalation: VAfrezza Vfor Vmealtime Vinsulin.
Insulin VDosing Vfor VType V1 Vand VType V2 V- V Vcorrect Vanswer- V VType V1: VInitial Vdoses V0.5-0.6
Vunits/kg/day. VType V2: VInitial Vdoses V0.2-0.6 Vunits/kg/day, Vadjusted Vbased Von Vcarb Vintake Vand
Vactivity.
3 VDosing VSchedules V- V Vcorrect Vanswer- V Vo VTwice Vdaily Vdosing
o VIntensive Vbasal/bolus Vstrategy
o VContinued Vsubcutaneous Vinsulin
Metformin VMechanism Vof VAction V- V Vcorrect Vanswer- V Vo VInhibits Vglucose Vproduction Vin Vthe
Vliver
o VReduces Vglucose Vabsorption Vin Vthe Vgut
o VSensitizes Vinsulin Vreceptors Vin Vtarget Vtissues V(fat Vand Vskeletal Vmuscle) Vto Vincrease Vglucose
Vuptake Vand Vresponse Vto Vinsulin
Drugs Vfor VGestational VDiabetes V- V Vcorrect Vanswer- V VMetformin Vand VInsulin
A1C VValue Vfor VDiabetes VMellitus V- V Vcorrect Vanswer- V V6.5% Vor Vgreater Vis Vdiabetes, V5.7-6.4%
Vpre-diabetes
Fasting Vand VRandom VValues Vfor VDM V- V Vcorrect Vanswer- V VFasting Vplasma Vglucose—126 Vor
Vgreater Vis Vdiabetes. VRandom Vplasma Vglucose—anything Vgreater Vthan V200 Vis Vdiabetes
Complications Vof VInsulin VTherapy V- V Vcorrect Vanswer- V VHypoglycemia, VLipohypertrophy, VAllergic
Vreactions, VDesensitization Vprocedure, VHypokalemia
,Insulin VDrug VInteractions V- V Vcorrect Vanswer- V VHypoglycemic Vagents Vintensify Vhypoglycemia, VUse
Vwith Vcaution Vwith Vhyperglycemic Vagents
Beta VBlockers' VEffect Von VInsulin V- V Vcorrect Vanswer- V VDelay Vawareness Vof Vhypoglycemia, VImpair
Vglycogenolysis, VPrevent Vcounter-regulatory Vresponse
Other VTherapeutic VUses V- V Vcorrect Vanswer- V VHyperkalemia, VDiagnosis Vof VGH Vdeficiency,
VDiabetic Vketoacidosis
Coordinating VInsulin VDosage V- V Vcorrect Vanswer- V VCarbohydrate Vintake
Blood VPressure VGoal Vin VDiabetes V- V Vcorrect Vanswer- V VControlled Vwithin Vnormal V120/80
Medication Vfor VDiabetic VNephropathy VRisk V- V Vcorrect Vanswer- V VACE Vinhibitor Vor VARB
Role Vof VExercise Vin VDM VTreatment V- V Vcorrect Vanswer- V VExercise Vincreases Vcellular
Vresponsiveness Vto Vinsulin Vand Vglucose Vtolerance. V150 Vminutes Vper Vweek Vof Vmoderate Vintensity
Vexercise Vis Vrecommended.
4-Step VApproach VSteps V- V Vcorrect Vanswer- V VStep V1: VDiagnosis Vand Vlifestyle Vchanges Vplus
Vmetformin. VStep V2: VLifestyle Vchanges, Vmetformin, Vand Va Vsecond Vdrug. VStep V3: VThree Vdrug
Vcombination. VStep V4: VComplex Vinsulin Vregimen Vif Vneeded.
Insulin VTherapy VBlood VGlucose VGoals V- V Vcorrect Vanswer- V VBefore Vmeals: V70-130. VBedtime: V100-
140.
A1C VGoal Vand VExceptions V- V Vcorrect Vanswer- V VA1C Vgoal Vis V7% Vor Vbelow. VExceptions: VSevere
Vhypoglycemia Vrisk, Vlimited Vlife Vexpectancy, Vadvanced Vcomplications.
, Types Vof VInsulins V- V Vcorrect Vanswer- V VShort Vacting: VRapid Vacting Vinsulins. VIntermediate: VNPH
Vinsulin, Vinsulin Vdetemir. VLong Vacting: VInsulin Vglargine.
Use Vof VShort VDuration VInsulins V- V Vcorrect Vanswer- V VAdministered Vwith Vmeals Vto Vcontrol Vpost-
prandial Vblood Vglucose Vrise.
Need Vfor VIntermediate VInsulins V- V Vcorrect Vanswer- V VAdministered V2-3 Vtimes Vdaily Vfor Vglycemic
Vcontrol Vbetween Vmeals Vand Vat Vnight.
Duration Vof VInsulins V- V Vcorrect Vanswer- V VGlargine: VUp Vto V24 Vhours. VLevemir: V12-24 Vhours.
VDegludec: VUp Vto V42 Vhours.
Routes Vof VInsulin VAdministration V- V Vcorrect Vanswer- V VSubcutaneous Vinjection Vand VIV Vinfusion.
VInhalation: VAfrezza Vfor Vmealtime Vinsulin.
Insulin VDosing Vfor VType V1 Vand VType V2 V- V Vcorrect Vanswer- V VType V1: VInitial Vdoses V0.5-0.6
Vunits/kg/day. VType V2: VInitial Vdoses V0.2-0.6 Vunits/kg/day, Vadjusted Vbased Von Vcarb Vintake Vand
Vactivity.
3 VDosing VSchedules V- V Vcorrect Vanswer- V Vo VTwice Vdaily Vdosing
o VIntensive Vbasal/bolus Vstrategy
o VContinued Vsubcutaneous Vinsulin
Metformin VMechanism Vof VAction V- V Vcorrect Vanswer- V Vo VInhibits Vglucose Vproduction Vin Vthe
Vliver
o VReduces Vglucose Vabsorption Vin Vthe Vgut
o VSensitizes Vinsulin Vreceptors Vin Vtarget Vtissues V(fat Vand Vskeletal Vmuscle) Vto Vincrease Vglucose
Vuptake Vand Vresponse Vto Vinsulin
